|
@@ -5,18 +5,18 @@
|
|
|
<p class="antibodyDetail_title">Adalimumab</p>
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Summary</p>
|
|
|
- <div class="Detail_boxContent">{{ overView.summary }}</div>
|
|
|
+ <div class="Detail_boxContent"> <p v-for="(one, i) in splitText(overView.summary)" :key="i">{{ one }}</p></div>
|
|
|
</div>
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Background</p>
|
|
|
<div class="Background_box">
|
|
|
<div class="Background_content Detail_line">
|
|
|
<p class="Background_title">Relationship to Disease</p>
|
|
|
- <p class="Background_text">{{ overView.relationshipToDisease }}</p>
|
|
|
+ <div class="Background_text"><p v-for="(one, i) in splitText(overView.relationshipToDisease)" :key="i">{{ one }}</p></div>
|
|
|
</div>
|
|
|
<div class="Background_content">
|
|
|
<p class="Background_title">Mechanism of action</p>
|
|
|
- <p class="Background_text">{{ overView.mechanismOfActionOne }}</p>
|
|
|
+ <div class="Background_text"><p v-for="(one, i) in splitText(overView.mechanismOfActionOne)" :key="i">{{ one }}</p></div>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
@@ -51,9 +51,9 @@
|
|
|
</div>
|
|
|
<div class="Background_bottom">
|
|
|
<p class="Background_title">Conditions</p>
|
|
|
- <p class="Background_text">
|
|
|
- <span class="drop">・</span><span v-html="formatText(overView.conditions)"></span>
|
|
|
- </p>
|
|
|
+ <div class="Background_text">
|
|
|
+ <p v-for="(one, i) in splitText(overView.conditions)" :key="i"><span class="drop">・</span>{{one}}</p>
|
|
|
+ </div>
|
|
|
</div>
|
|
|
</div>
|
|
|
<div class="Properties_content Properties_Right">
|
|
@@ -87,7 +87,9 @@
|
|
|
</div>
|
|
|
<div class="Background_bottom">
|
|
|
<p class="Background_title">Structure</p>
|
|
|
- <img class="Background_img" :src="overView.structureUrl" alt="">
|
|
|
+ <div class="Background_text">
|
|
|
+ <img class="Background_img" :src="overView.structureUrl" alt="">
|
|
|
+ </div>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
@@ -155,43 +157,28 @@
|
|
|
<div class="Background_box">
|
|
|
<div class="Background_content Detail_line">
|
|
|
<p class="Background_title">Toxicity</p>
|
|
|
- <p class="Background_text">{{ overView.toxicity }}</p>
|
|
|
+ <div class="Background_text"><p v-for="(one, i) in splitText(overView.toxicity)" :key="i">{{ one }}</p></div>
|
|
|
</div>
|
|
|
<div class="Background_content">
|
|
|
<p class="Background_title">Mechanism ofaction</p>
|
|
|
- <p class="Background_text">{{ overView.mechanismOfActionOne }}</p>
|
|
|
+ <div class="Background_text"><p v-for="(one, i) in splitText(overView.mechanismOfActionOne)" :key="i">{{ one }}</p></div>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
|
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Marketing</p>
|
|
|
- <div class="Background_box" style="height: 200px;">
|
|
|
+ <div class="Background_box" style="height: 200px;padding: 20px;">
|
|
|
+ <img style="height: 100%;display: block;margin: auto;" :src="overView.marketingUrl" alt="">
|
|
|
</div>
|
|
|
</div>
|
|
|
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">History</p>
|
|
|
<div class="history_box">
|
|
|
- <div class="history_content">
|
|
|
+ <div class="history_content" v-for="(one, i) in splitText(overView.history)" :key="i">
|
|
|
<p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
+ <p>{{ one }}</p>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
@@ -199,25 +186,9 @@
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Frontier Literature</p>
|
|
|
<div class="history_box">
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
- <p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
- </div>
|
|
|
- <div class="history_content">
|
|
|
+ <div class="history_content" v-for="(one, index) in overView.frontierLiteratureList" :key="index">
|
|
|
<p class="drop">・</p>
|
|
|
- <p>Adalimumab was the first fully human monoclonal antibody approved by the US Foodand Drug Administration (FDA). The drug candidate was discovered initially using CAT'sphage display technology and named D2E7.</p>
|
|
|
+ <p>{{ one.contentOne }}</p>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
@@ -225,21 +196,13 @@
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Data Source</p>
|
|
|
<div class="source_box">
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
+ <p v-for="(one, index) in overView.dataSourceList" :key="index">[{{ index + 1 }}] {{ one.contentOne }}</p>
|
|
|
</div>
|
|
|
</div>
|
|
|
<div class="antibodyDetail_box">
|
|
|
<p class="Detail_boxTitle">Patent</p>
|
|
|
<div class="source_box">
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
- <p>[1] https://go.drugbank.com/drugs/DB00051</p>
|
|
|
+ <p v-for="(one, index) in overView.patentList" :key="index">[{{ index + 1 }}] {{ one.contentOne }}</p>
|
|
|
</div>
|
|
|
</div>
|
|
|
</div>
|
|
@@ -258,6 +221,12 @@ export default {
|
|
|
};
|
|
|
},
|
|
|
methods: {
|
|
|
+ // 根据;;分割字符串
|
|
|
+ splitText(text) {
|
|
|
+ if (text) {
|
|
|
+ return text.split(";;");
|
|
|
+ }
|
|
|
+ },
|
|
|
changeSearchById() {
|
|
|
this.$api.post("/basb/searchById", {
|
|
|
id: this.$route.query.id
|
|
@@ -308,11 +277,11 @@ export default {
|
|
|
box-sizing: border-box;
|
|
|
font-size: 14px;
|
|
|
line-height: 18px;
|
|
|
- margin: 5px 0 20px;
|
|
|
+ margin: 10px 0 20px;
|
|
|
}
|
|
|
.Background_box{
|
|
|
border: 2px solid #0259AE;
|
|
|
- margin: 5px 0 20px;
|
|
|
+ margin: 10px 0 20px;
|
|
|
font-size: 14px;
|
|
|
line-height: 18px;
|
|
|
.Background_content{
|
|
@@ -340,7 +309,7 @@ export default {
|
|
|
.Properties_content{
|
|
|
width: 50%;
|
|
|
border: 2px solid #0259AE;
|
|
|
- margin: 5px 0 20px;
|
|
|
+ margin: 10px 0 20px;
|
|
|
font-size: 14px;
|
|
|
line-height: 18px;
|
|
|
display: flex;
|
|
@@ -364,17 +333,23 @@ export default {
|
|
|
box-sizing: border-box;
|
|
|
flex: 1;
|
|
|
height: 100%;
|
|
|
+ position: relative;
|
|
|
}
|
|
|
.Background_img{
|
|
|
+ position: absolute;
|
|
|
+ display: block;
|
|
|
min-height: 38px;
|
|
|
background: #fff;
|
|
|
- border-left: 1px solid #DDDDDD;
|
|
|
+ // border-left: 1px solid #DDDDDD;
|
|
|
padding: 10px;
|
|
|
box-sizing: border-box;
|
|
|
flex: 1;
|
|
|
- height: 100%;
|
|
|
- width: 100px;
|
|
|
+ width: 60%;
|
|
|
+ left: 50%;
|
|
|
+ top: 50%;
|
|
|
+ transform: translate(-50%,-50%);
|
|
|
}
|
|
|
+
|
|
|
}
|
|
|
.Background_content{
|
|
|
display: flex;
|
|
@@ -443,11 +418,11 @@ export default {
|
|
|
}
|
|
|
.history_box{
|
|
|
border: 2px solid #0259AE;
|
|
|
- padding: 5px 10px;
|
|
|
+ padding: 20px 10px;
|
|
|
box-sizing: border-box;
|
|
|
font-size: 14px;
|
|
|
line-height: 18px;
|
|
|
- margin: 5px 0 20px;
|
|
|
+ margin: 10px 0 20px;
|
|
|
.history_content{
|
|
|
display: flex;
|
|
|
margin-bottom: 15px;
|
|
@@ -455,11 +430,11 @@ export default {
|
|
|
}
|
|
|
.source_box{
|
|
|
border: 2px solid #0259AE;
|
|
|
- padding: 5px 10px;
|
|
|
+ padding: 20px 10px;
|
|
|
box-sizing: border-box;
|
|
|
font-size: 14px;
|
|
|
line-height: 22px;
|
|
|
- margin: 5px 0 20px;
|
|
|
+ margin: 10px 0 20px;
|
|
|
color: #0259AE;
|
|
|
}
|
|
|
}
|